128 related articles for article (PubMed ID: 11504649)
1. Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists.
McCort G; Hoornaert C; Aletru M; Denys C; Duclos O; Cadilhac C; Guilpain E; Dellac G; Janiak P; Galzin AM; Delahaye M; Guilbert F; O'Connor S
Bioorg Med Chem; 2001 Aug; 9(8):2129-37. PubMed ID: 11504649
[TBL] [Abstract][Full Text] [Related]
2. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction.
Galzin AM; Delahaye M; Hoornaert C; McCort G; O'Connor SE
Eur J Pharmacol; 2000 Sep; 404(3):361-8. PubMed ID: 10996601
[TBL] [Abstract][Full Text] [Related]
3. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.
O'Connor SE; Grosset A; La Rochelle CD; Gautier E; Bidouard JP; Robineau P; Caille D; Janiak P
Eur J Pharmacol; 2001 Mar; 414(2-3):259-69. PubMed ID: 11239927
[TBL] [Abstract][Full Text] [Related]
6. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
[TBL] [Abstract][Full Text] [Related]
7. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
[TBL] [Abstract][Full Text] [Related]
9. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
11. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
Pertz HH; Milhahn H; Eich E
J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.
Mensonides-Harsema MM; Liao Y; Böttcher H; Bartoszyk GD; Greiner HE; Harting J; de Boer P; Wikström HV
J Med Chem; 2000 Feb; 43(3):432-9. PubMed ID: 10669570
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.
Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
Bioorg Med Chem Lett; 2002 Jan; 12(2):249-53. PubMed ID: 11755365
[TBL] [Abstract][Full Text] [Related]
17. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
[TBL] [Abstract][Full Text] [Related]
18. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine.
Jorand-Lebrun C; Pauwels PJ; Palmier C; Moret C; Chopin P; Perez M; Marien M; Halazy S
J Med Chem; 1997 Nov; 40(24):3974-8. PubMed ID: 9397179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
